Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases
Hand-out
Press Releases
January 8, 2025

Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases

Oversubscribed Series A financing led by Frazier Life Sciences and Droia Ventures

bradford

The Bradford Era

Local & Social